Company
Headquarters: Dalian, China
Employees: 3,199
CN¥15.14 Billion
CNY as of Jan. 1, 2025
US$2.07 Billion
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.80 B |
| Cencora, Inc. | $47.92 B |
| Cardinal Health, Inc. | $31.29 B |
| Henry Schein, Inc. | $9.32 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.01 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Liaoning Cheng Da Co., Ltd. engages in trading, medicine and medical care, financial investment, and energy development businesses in China and internationally. The company trades in textile and apparel, chemical products, coal, aquatic products, timber, and steel; and offers medical insurance. It is also involved in the research, development, production, and marketing of human and veterinary vaccines; pharmaceutical retail and wholesale, and logistics distribution activities; the provision of medical enterprise management consulting; and sale of medical equipment. In addition, the company offers medical technology, computer hardware and software technology development, technology consulting and transfer, and technical services. Further, it engages in securities and fund activities; and the development of oil shale projects. Liaoning Cheng Da Co., Ltd. was founded in 1991 and is headquartered in Dalian, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥11.29 B |
| EBITDA | CN¥1.45 B |
| Gross Profit TTM | CN¥1.03 B |
| Profit Margin | 3.07% |
| Operating Margin | 3.03% |
| Quarterly Revenue Growth | -6.50% |
Liaoning Cheng Da Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600739 wb_incandescent